Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations.
Amir AbdelwahabMartin GardnerRatika ParkashChristopher GrayJohn SappPublished in: Journal of cardiovascular electrophysiology (2017)
TMEM43 mutation patients were more likely to have biventricular arrhythmogenic substrate and more inducible VTs at EP study. Despite comparable acute VT ablation outcomes, long-term prognosis is unfavorable.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- liver failure
- heart failure
- prognostic factors
- peritoneal dialysis
- respiratory failure
- patient reported outcomes
- adipose tissue
- skeletal muscle
- left ventricular
- patient reported
- weight loss
- cardiac resynchronization therapy
- acute respiratory distress syndrome
- glycemic control